A Rare Presentation of a Bi-Maxillary Brown Tumour Due to Secondary Hyperparathyroidism

Overview

Journal Case Rep Dent

Publisher Wiley

Specialty Dentistry

Date 2023 Apr 6

PMID 37021075

Authors

Cheboh Cho-Fon

Zilefac Brian Ngokwe

Obolo Nwaga Ines

Affiliations

Soon will be listed here.

Abstract

Brown tumours are localized bone lesions, seen in patients with high parathyroid hormone levels. This can be due to primary hyperparathyroidism, which occurs more often in neoplasms of the parathyroid gland or due to secondary hyperparathyroidism more often seen as a result of renal impairment. Facial involvement is rare, with most reports focusing on long and axial bones. However, the mandibular bone is often the only bone affected. Here, we report a rare case of a bi-maxillary attainment of brown tumour in a patient with secondary hyperparathyroidism due to chronic kidney disease.

References

Liyanage T, Ninomiya T, Jha V, Neal B, Patrice H, Okpechi I . Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015; 385(9981):1975-82. DOI: 10.1016/S0140-6736(14)61601-9. View

Kovesdy C, Ahmadzadeh S, Anderson J, Kalantar-Zadeh K . Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney Int. 2008; 73(11):1296-302. DOI: 10.1038/ki.2008.64. View

Neuen B, Chadban S, Demaio A, Johnson D, Perkovic V . Chronic kidney disease and the global NCDs agenda. BMJ Glob Health. 2017; 2(2):e000380. PMC: 5717948. DOI: 10.1136/bmjgh-2017-000380. View

Abdu A, Abdu A, Arogundade F . Prevalence and pattern of chronic kidney disease-mineral bone disorders among hemodialysis patients in kano, northwest nigeria. Ann Afr Med. 2019; 18(4):191-195. PMC: 6918790. DOI: 10.4103/aam.aam_18_19. View

Selvi F, Cakarer S, Tanakol R, Guler S, Keskin C . Brown tumour of the maxilla and mandible: a rare complication of tertiary hyperparathyroidism. Dentomaxillofac Radiol. 2008; 38(1):53-8. DOI: 10.1259/dmfr/81694583. View

Hou Y, Lu C, Lu K . Mineral bone disorders in chronic kidney disease. Nephrology (Carlton). 2018; 23 Suppl 4:88-94. DOI: 10.1111/nep.13457. View

Tbini M, Essefi E, Kamel H, Riahi I, Ben Salah M . Palatal swelling revealing a secondary hyperparathyroidism: A case report. Int J Surg Case Rep. 2023; 103:107899. PMC: 9860407. DOI: 10.1016/j.ijscr.2023.107899. View

Can O, Boynuegri B, Gokce A, Ozdemir E, Ferhatoglu F, Canbakan M . Brown Tumors: A Case Report and Review of the Literature. Case Rep Nephrol Dial. 2016; 6(1):46-52. PMC: 4821153. DOI: 10.1159/000444703. View

Ene-Iordache B, Perico N, Bikbov B, Carminati S, Remuzzi A, Perna A . Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. Lancet Glob Health. 2016; 4(5):e307-19. DOI: 10.1016/S2214-109X(16)00071-1. View

10.

Xu Y, Evans M, Soro M, Barany P, Carrero J . Secondary hyperparathyroidism and adverse health outcomes in adults with chronic kidney disease. Clin Kidney J. 2021; 14(10):2213-2220. PMC: 8483675. DOI: 10.1093/ckj/sfab006. View

11.

Kaze F, Meto D, Halle M, Ngogang J, Kengne A . Prevalence and determinants of chronic kidney disease in rural and urban Cameroonians: a cross-sectional study. BMC Nephrol. 2015; 16:117. PMC: 4518633. DOI: 10.1186/s12882-015-0111-8. View

12.

Bransky N, Iyer N, Cannon S, Tyan A, Mylavarapu P, Orosco R . Three Rare Concurrent Complications of Tertiary Hyperparathyroidism: Maxillary Brown Tumor, Uremic Leontiasis Ossea, and Hungry Bone Syndrome. J Bone Metab. 2020; 27(3):217-226. PMC: 7571245. DOI: 10.11005/jbm.2020.27.3.217. View

13.

Kaze F, Halle M, Mopa H, Ashuntantang G, Fouda H, Ngogang J . Prevalence and risk factors of chronic kidney disease in urban adult Cameroonians according to three common estimators of the glomerular filtration rate: a cross-sectional study. BMC Nephrol. 2015; 16:96. PMC: 4492095. DOI: 10.1186/s12882-015-0102-9. View

14.

Adnane A, Merzem A, Harmak M, Belgadir H, Amriss O, Moussali N . [Imaging features of multiple maxillomandibular brown tumors: a case report]. Pan Afr Med J. 2021; 38:4. PMC: 7825377. DOI: 10.11604/pamj.2021.38.4.27141. View

15.

. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388(10053):1459-1544. PMC: 5388903. DOI: 10.1016/S0140-6736(16)31012-1. View

16.

Tonelli M, Agarwal S, Cass A, Garcia G, Jha V, Naicker S . How to advocate for the inclusion of chronic kidney disease in a national noncommunicable chronic disease program. Kidney Int. 2013; 85(6):1269-74. DOI: 10.1038/ki.2012.488. View

17.

Aseneh J, Kemah B, Mabouna S, Njang M, Ekane D, Agbor V . Chronic kidney disease in Cameroon: a scoping review. BMC Nephrol. 2020; 21(1):409. PMC: 7510319. DOI: 10.1186/s12882-020-02072-5. View